Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Shares Outstanding (Weighted Average) (2018 - 2025)

Dna X (SONM) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $614985.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 137.64% year-over-year to $614985.0, compared with a TTM value of $614985.0 through Sep 2025, up 137.64%, and an annual FY2024 reading of $4.7 million, up 10.04% over the prior year.
  • Shares Outstanding (Weighted Average) was $614985.0 for Q3 2025 at Dna X, down from $7.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $40.9 million in Q1 2023 and bottomed at $258788.0 in Q3 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $10.7 million, with a median of $6.6 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 244.6% in 2022, then plummeted 93.99% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $9.5 million in 2021, then surged by 205.23% to $28.9 million in 2022, then tumbled by 85.16% to $4.3 million in 2023, then rose by 10.04% to $4.7 million in 2024, then plummeted by 86.97% to $614985.0 in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SONM at $614985.0 in Q3 2025, $7.7 million in Q2 2025, and $5.8 million in Q1 2025.